**Core Concept**
Tyrosine kinase inhibitors (TKIs) are a class of medications that block specific enzymes called tyrosine kinases, which play a crucial role in the activation of various proteins involved in cell signaling pathways. By inhibiting these enzymes, TKIs can disrupt abnormal cell growth and proliferation, making them effective in treating certain types of cancer.

**Why the Correct Answer is Right**
Tyrosine kinase inhibitors target specific tyrosine kinases involved in cancer cell growth and survival. For example, imatinib targets the BCR-ABL tyrosine kinase in chronic myeloid leukemia (CML), while erlotinib targets the epidermal growth factor receptor (EGFR) tyrosine kinase in non-small cell lung cancer (NSCLC). By inhibiting these kinases, TKIs can induce apoptosis and slow disease progression.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while TKIs are used in the treatment of various types of cancer, they are not typically used for the treatment of heart failure.
**Option B:** This option is incorrect because while TKIs may be used in the treatment of certain autoimmune disorders, such as rheumatoid arthritis, they are not the primary treatment option.
**Option C:** This option is incorrect because while TKIs may be used in the treatment of certain viral infections, such as HIV, they are not the primary treatment option.

**Clinical Pearl / High-Yield Fact**
One key thing to remember is that TKIs are often used in combination with other therapies, such as chemotherapy or radiation, to enhance their efficacy and reduce the risk of resistance.

**Correct Answer: C. Cancer.